A Disintegrin and Metalloprotease 12 Promotes Tumor Progression by Inhibiting Apoptosis in Human Colorectal Cancer
Authors:
- Young-Lan ParkYPYoung-Lan Park
- Sun-Young ParkSPSun-Young Park
- Hyung-Hoon OhHOHyung-Hoon Oh
- Min-Woo ChungMCMin-Woo Chung
- Ji-Yun HongJHJi-Yun Hong
- Ki-Hyun KimKKKi-Hyun Kim
- Dae-Seong MyungDMDae-Seong Myung
- Sung-Bum ChoSCSung-Bum Cho
- Wan-Sik LeeWLWan-Sik Lee
- Hyun-Soo KimHKHyun-Soo Kim
- Young-Eun JooYJYoung-Eun Joo
Open Access
Abstract
A disintegrin and metalloprotease 12 (ADAM12) has been implicated in cell growth, tumor formation, and metastasis. Therefore, we evaluated the role of ADAM12 in colorectal cancer (CRC) progression and prognosis, and elucidated whether targeted downregulation of ADAM12 could lead to therapeutic sensitization. The effect of ADAM12 on tumor cell behavior was assessed in CRC cell lines, CRC tissues, and a mouse xenograft model. ADAM12 overexpression enhanced proliferation, inhibited apoptosis, and acted as positive regulator of cell cycle progression in CRC cells. Phosphorylation of PTEN was decreased and that of Akt was increased by ADAM12 overexpression. These results were reversed upon ADAM12 knockdown. ADAM12 overexpression was significantly associated with the cancer stage, depth of invasion, lymph node metastasis, distant metastasis, and poor survival in CRC patients. In a mouse xenograft model, tumor area, volume, and weight were significantly greater for the ADAM12-pcDNA6-myc-transfected group than for the empty-pcDNA6-myc-transfected group, and significantly lower for the ADAM12-pGFP-C-shLenti-transfected group than for the scrambled pGFP-C-shLenti-transfected group. In conclusion, ADAM12 overexpression is essential for the growth and progression of CRC. Furthermore, ADAM12 knockdown reveals potent anti-tumor activity in a mouse xenograft model. Thus, ADAM12 may serve as a promising biomarker and/or therapeutic target in CRC.Keywords
This publication has 37 references indexed in Scilit:
- ADAM12 Produced by Tumor Cells Rather than Stromal Cells Accelerates Breast Tumor ProgressionMolecular Cancer Research, 2011
- ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor GrowthJournal of Biological Chemistry, 2011
- ADAM12 induces estrogen-independence in breast cancer cellsBreast Cancer Research and Treatment, 2011
- The role of the tissue microenvironment in the regulation of cancer cell motility and invasionCell Communication and Signaling, 2010
- Transforming Growth Factor-β1–Mediated Activation of NF-κB Contributes to Enhanced ADAM-12 Expression in Mammary Carcinoma CellsMolecular Cancer Research, 2010
- The “A Disintegrin And Metalloprotease” (ADAM) family of sheddases: Physiological and cellular functionsSeminars in Cell & Developmental Biology, 2009
- Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk AssessmentCancer Epidemiology, Biomarkers & Prevention, 2008
- ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progressionOncogene, 2006
- A Role for ADAM12 in Breast Tumor Progression and Stromal Cell ApoptosisCancer Research, 2005
- Adam12 in Human Liver Cancers: Tgf–β–Regulated Expression in Stellate Cells Is Associated With Matrix RemodelingHepatology, 2003